Loading...
XNASALTS
Market cap76mUSD
Jan 13, Last price  
5.69USD
1D
-2.32%
1Q
249.17%
Jan 2017
12.86%
IPO
-78.06%
Name

Janone Inc

Chart & Performance

D1W1MN
XNAS:ALTS chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
21.79%
Rev. gr., 5y
-0.95%
Revenues
0k
-100.00%
52,830,00074,893,00077,790,000100,765,000110,971,000101,269,000108,162,000126,669,000114,313,000129,061,000130,930,000111,839,000103,589,00041,544,00036,794,00035,097,00033,867,00040,022,00039,611,0000
Net income
-20m
L
-1,314,000-933,000-1,409,0002,539,000360,000-3,338,0002,009,0004,461,000-3,852,0003,318,000771,000-2,717,000-1,451,000118,000-5,608,000-11,964,000-8,498,000-16,887,0003,589,000-20,060,000
CFO
1m
P
267,000-2,149,000-10,000-6,248,0001,649,0001,336,0003,475,0001,376,000551,0001,740,0003,595,000-3,409,0002,659,0001,226,0004,145,000-3,510,000-617,000-5,292,000-3,056,0001,463,000
Earnings
Apr 07, 2025

Profile

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
IPO date
Feb 22, 2006
Employees
199
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122022‑002021‑002019‑122018‑122017‑122016‑122016‑00
Income
Revenues
39,611
16.96%
Cost of revenue
1,500
31,992
Unusual Expense (Income)
NOPBT
(1,500)
7,619
NOPBT Margin
19.23%
Operating Taxes
(429)
(6,671)
Tax Rate
NOPAT
(1,071)
14,290
Net income
(20,060)
18.79%
3,589
-142.23%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,051
BB yield
-47.28%
Debt
Debt current
6,692
Long-term debt
707
11,208
Deferred revenue
Other long-term liabilities
34
46
Net debt
416
17,470
Cash flow
Cash from operating activities
1,463
(3,056)
CAPEX
(1,509)
Cash from investing activities
(155)
(1,509)
Cash from financing activities
(1,435)
3,979
FCF
1,842
9,141
Balance
Cash
5
115
Long term investments
286
315
Excess cash
291
Stockholders' equity
(50,631)
(28,931)
Invested Capital
62,574
51,759
ROIC
31.00%
ROCE
33.09%
EV
Common stock shares outstanding
4,005
3,150
Price
0.56
-86.43%
1.37
-71.98%
Market cap
2,223
-79.56%
4,316
-52.35%
EV
17,149
36,296
EBITDA
8,231
EV/EBITDA
4.41
Interest
489
Interest/NOPBT
6.42%